Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.

The PubMed database was searched from January 2018 to May 2024. Articles were selected for inclusion if they reported on patients with metastatic prostate cancer who received a germline or somatic ...

Common metastasis sites include lung, bone, and lymph nodes, with 46% of patients having metastases in two or more sites. Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell ...

Journal of Nuclear Medicine January 2025, jnumed.124.268275; DOI: https://doi.org/10.2967/jnumed.124.268275 ...